10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 255 filers reported holding 10X GENOMICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $388,560 | +31.7% | 10,663 | +2.9% | 0.02% | +19.0% |
Q3 2022 | $295,000 | -39.3% | 10,363 | -3.4% | 0.02% | -32.3% |
Q2 2022 | $486,000 | -44.0% | 10,732 | -5.9% | 0.03% | -13.9% |
Q1 2022 | $868,000 | -53.7% | 11,410 | -9.4% | 0.04% | -41.0% |
Q4 2021 | $1,876,000 | -12.3% | 12,591 | -14.3% | 0.06% | -15.3% |
Q3 2021 | $2,139,000 | -13.7% | 14,691 | +16.1% | 0.07% | -13.3% |
Q2 2021 | $2,478,000 | +6.2% | 12,659 | -1.8% | 0.08% | -7.8% |
Q1 2021 | $2,333,000 | +18.7% | 12,887 | -7.2% | 0.09% | +4.7% |
Q4 2020 | $1,966,000 | +40.0% | 13,884 | +23.3% | 0.09% | +19.4% |
Q3 2020 | $1,404,000 | +513.1% | 11,264 | +338.6% | 0.07% | +453.8% |
Q2 2020 | $229,000 | – | 2,568 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |